Literature DB >> 7205219

2,5-Diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone I: Kinetics in aqueous solutions by high-performance liquid chromatography.

G K Poochikian, J C Cradock.   

Abstract

The application of a rapid, selective, and sensitive reversed-phase high-performance liquid chromatographic method to the analysis of 2,5-diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone (I) and its degradation products is described. The method was used to study the kinetics of degradation of I over pharmaceutically useful pH ranges. The overall reaction rate followed pseudo-first-order kinetics. The pH-rate profile demonstrated optimal stability between pH 6.0 and 6.5. The degradation behavior suggests the existence of multiple pathways. The temperature dependence of th disappearance of I also was evaluated from the regression equation derived from the Arrhenius plot.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7205219     DOI: 10.1002/jps.2600700211

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

1.  Improved dissolution of oleanolic acid with ternary solid dispersions.

Authors:  Longxiao Liu; Xiaocui Wang
Journal:  AAPS PharmSciTech       Date:  2007-12-21       Impact factor: 3.246

2.  Phase II evaluation of diaziquone (CI-904, AZQ) in the treatment of human malignant glioma.

Authors:  J Maral; M Poisson; B F Pertuiset; P Mashaly; M Weil; C Jacquillat; A J Grillo-Lopez
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

Review 3.  Diaziquone (AZQ).

Authors:  J F Bender; A J Grillo-Lopez; J G Posada
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

4.  Intracerebral penetration and tissue distribution of 2,5-diaziridinyl 3,6-bis(carboethoxyamino) 1,4-benzoquinone (AZQ, NSC-182986).

Authors:  N Savaraj; K Lu; L G Feun; M E Leavens; D Stewart; M A Burgess; R S Benjamin; T L Loo
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

5.  Stability of 2,5-diaziridinyl-3,6-bis(2-hydroxyethylamino)-1,4-benzoquinone (BZQ; NSC 224070) in aqueous solutions by high-performance liquid chromatography.

Authors:  A G Bosanquet; S B McLoughlin
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

6.  Thiol oxidation coupled to DT-diaphorase-catalysed reduction of diaziquone. Reductive and oxidative pathways of diaziquone semiquinone modulated by glutathione and superoxide dismutase.

Authors:  I D Ordoñez; E Cadenas
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

7.  A phase I/II study of 24 hour intravenous AZQ in recurrent primary brain tumors.

Authors:  M C Chamberlain; M D Prados; P Silver; V A Levin
Journal:  J Neurooncol       Date:  1988-12       Impact factor: 4.130

Review 8.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. General considerations, the nitrosoureas and alkylating agents.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.